Cargando…
CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer
Background: Endometrial cancer (EC) is one of the most common and prevalent gynecologic malignancies worldwide. The aim of this study was to identify a novel therapeutic target for endometrioid endometrial cancer. Materials and Methods: Bioinformatic analysis was performed and CDK1 was screen out as...
Autores principales: | Ying, Xue, Che, Xuan, Wang, Jianzhang, Zou, Gen, Yu, Qin, Zhang, Xinmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974891/ https://www.ncbi.nlm.nih.gov/pubmed/33758599 http://dx.doi.org/10.7150/jca.51139 |
Ejemplares similares
-
VEGF Immunoexpression in Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022) -
Snail Immunoexpression in Endometrioid Endometrial Carcinomas
por: FLORESCU, MIRELA MARINELA, et al.
Publicado: (2022) -
Integrating Spatial Transcriptomics and Single-nucleus RNA Sequencing Reveals the Potential Therapeutic Strategies for Uterine Leiomyoma
por: Wang, Jianzhang, et al.
Publicado: (2023) -
Clinicopathological Prognostic Parameters of Endometrioid Endometrial Carcinomas
por: DROCAŞ, ILEANA, et al.
Publicado: (2022) -
Recepteur d'origine nantais contributes to the development of endometriosis via promoting epithelial‐mesenchymal transition of a endometrial epithelial cells
por: Yu, Qin, et al.
Publicado: (2021)